CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Show More...
-
Website https://www.cormedix.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 11.36 USD
-
Last Updated 14-07-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -5.75 -2.9 -1.5 -3.45 -4.8 -2.9 -3.25 -3.0 -1.51 -1.8 -1.79 Dividends USD Payout Ratio % * Shares Mil 2.0 2.0 2.0 3.0 4.0 6.0 8.0 11.0 18.0 24.0 25.0 Book Value Per Share * USD 3.18 0.32 -0.21 -0.88 1.24 5.06 2.94 0.68 -0.44 1.12 0.83 Free Cash Flow Per Share * USD -1.94 -2.85 -1.0 -1.28 -1.44 -1.86 -2.65 -2.87 -1.5 -0.8 Return on Assets % -196.96 -117.7 -184.71 -461.89 -509.23 -86.35 -83.53 -186.71 -166.23 -180.27 -160.58 Financial Leverage (Average) 1.22 2.07 1.4 1.09 1.23 1.87 3.82 1.25 1.27 Return on Equity % -158.06 -900.13 -96.8 -95.1 -264.01 -442.49 -304.66 -230.37 Return on Invested Capital % -158.33 -468.19 -97.1 -95.59 -264.85 -220.4 -248.82 -196.38 Interest Coverage -2.62 -7.95 -5.32 -26.29 -43.5 Current Ratio 5.59 1.94 0.7 1.74 3.53 12.11 5.34 2.12 2.4 5.04 4.7 Quick Ratio 5.26 1.9 0.52 1.42 3.1 11.66 4.93 1.92 2.27 4.86 4.0 Debt/Equity 1.24